Sanj Patel
Chief Executive Officer chez KINIKSA PHARMACEUTICALS, LTD.
Fortune : 34 M $ au 31/03/2024
Postes actifs de Sanj Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Chief Executive Officer | 01/07/2015 | - |
Chairman | 01/07/2015 | - | |
Founder | 01/07/2015 | - | |
Sarcoma Foundation of America | Director/Board Member | 01/01/2015 | - |
Founder | 01/01/2015 | - | |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The private company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Historique de carrière de Sanj Patel
Anciens postes connus de Sanj Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 29/09/2015 | 20/06/2018 |
Independent Dir/Board Member | 29/09/2015 | 20/06/2018 | |
SYROS PHARMACEUTICALS, INC. | Director/Board Member | 01/05/2016 | 14/06/2018 |
Independent Dir/Board Member | 01/05/2016 | 14/06/2018 | |
INTERCEPT PHARMACEUTICALS, INC. | Director/Board Member | 17/02/2014 | 24/11/2015 |
Independent Dir/Board Member | 17/02/2014 | 24/11/2015 | |
SYNAGEVA BIOPHARMA CORP | Director/Board Member | 01/06/2008 | 22/06/2015 |
Chief Executive Officer | 01/06/2008 | 22/06/2015 | |
President | 01/06/2008 | 22/06/2015 | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1999 | 01/01/2008 |
Formation de Sanj Patel
London South Bank University | Undergraduate Degree |
Ealing Hammersmith & West London College | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Royaume-Uni | 3 |
Opérationnelle
Director/Board Member | 6 |
Chief Executive Officer | 3 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Sarcoma Foundation of America | Miscellaneous |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The private company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Bourse
- Insiders
- Sanj Patel
- Expérience